Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


Delayed London Stock Exchange  -  11:35:20 2023-01-27 am EST
10622.00 GBX   -0.21%
01/26US FDA Cancels Emergency Use Nod For AstraZeneca's COVID-19 Drug
01/26ADRs End Higher; AstraZeneca, Diageo Trade Actively
01/26AstraZeneca loses emergency use authorisation for Evusheld
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

LONDON MARKET OPEN: Stocks up as protests in China deterred by police

11/29/2022 | 04:00am EST

(Alliance News) - The FSTE 100 opened in the green on Tuesday as investors were reassured that civil unrest in China would be short lived amid unyielding action by the authorities.

"Police in China have quashed mass Covid demonstrations for now, helping stocks regain their footing on indices across Asia, setting the tone for a positive open in Europe," said Susannah Streeter at Hargreaves Lansdown.

The FTSE 100 index opened up 64.88 points, 0.9%, at 7,538.90. The FTSE 250 was up 11.98 points, 0.1%, at 19,304.33, while the AIM All-Share was down 1.52 points, or 0.2% at 849.40.

The Cboe UK 100 was up 0.8% at 753.71, the Cboe UK 250 was down 0.2% at 16,700.37, and the Cboe Small Companies was up 0.6% at 13,219.22.

In Europe, the CAC 40 index in Paris was up 0.3% and the DAX 40 in Frankfurt was up 0.1%.

China's major cities of Beijing and Shanghai were blanketed with security in the wake of nationwide rallies calling for political freedoms and an end to Covid lockdowns.

The country's leadership is facing a wave of protest not seen in decades, fuelled by anger over the unrelenting lockdowns as well as deep-rooted frustrations over China's political direction.

With police cars, foot patrols, a network of surveillance cameras, and aided by the icy wind, Beijing authorities appeared to have deterred fresh gatherings.

In semi-autonomous Hong Kong, however, where mass democracy protests erupted in 2019, dozens gathered at the Chinese University to mourn the victims of the Urumqi fire. The demonstrators said Covid restrictions were to blame for hampering rescue efforts of the deadly fire.

As the police cracked down on protesters, stocks in China closed firmly in the green on Tuesday. The Shanghai Composite closed up 2.3%, and the Hang Seng in Hong Kong closed up sharply, ending 5.2% higher.

The Nikkei 225 in Tokyo ended up 0.5% and the S&P/ASX 200 in Sydney closed up 0.3%.

News that China said it would speed up a push to vaccinate people aged 60 and older against Covid-19 also helped to boost Asian stocks and investor confidence elsewhere.

In London, AstraZeneca agreed to acquire Neogene Therapeutics, a clinical stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies for the treatment of cancer.

AstraZeneca said it will pay up to USD320 million. This will include an initial cash payment of USD200 million upon closing and a further USD120 million, contingent on the meeting of unspecified milestones.

Shares in AstraZeneca were up 0.7%

FTSE 250-listed healthcare sector investor Syncona, which holds an 8% stake in Neogene, said it will receive USD16 million from Astra's initial payment.

Shares in Syncona were up 1.2%.

easyJet reported a "record bounce back" in the year ended September 30, with a sharp rise in annual revenue and a significantly narrowed loss.

The low-cost airline's pretax loss narrowed to GBP208 million from GBP1.04 billion the previous year, as revenue multiplied to GBP5.77 billion from GBP1.46 billion the year prior.

easyJet credited the relaxation of pandemic restrictions and an increase in ancillary products for the revenue rise.

Shares in the airline were down 2.0%.

John Wood Group said its trading in the first ten months of 2022 was in line with its expectations. As a result, the company confirmed its full-year guidance.

It expects annual revenue between USD5.2 billion and USD5.5 billion, with adjusted earnings before interest, tax, depreciation and amortisation around the middle of its guidance range of USD370 million and USD400 million.

The guidance saw John Wood plummet 12% in early morning trade.

Elsewhere, Treatt announced a rise in annual revenue but a fall in profit amid negative impacts from Covid restrictions in China, volatile currency movements, and cost inflation.

In the financial year that ended September 30, the ingredient supplier for the beverage, flavour and fragrance industry reported a pretax profit of GBP16.2 million, down from GBP19.6 million the previous year.

Cost of sales jumped to GBP101.1 million from GBP82.1 million, offsetting revenue which grew to GBP140.2 million from GBP124.3 million.

Shares in Treatt were down 1.6%.

The pound was quoted at USD1.2027 early Tuesday in London, a touch higher from USD1.2025 at the London equities close on Monday. Against the yen, the dollar was trading at JPY138.20, down from JPY138.89.

The euro stood at USD1.0368 shortly after the European equities open on Tuesday morning, lower against USD1.0377 late Monday.

For ING's Francesco Pesole, the key for the US dollar moving forward will be Wednesday's speech by Fed Chair Jerome Powell, in which Pesole sees a "higher likelihood that he will sound hawkish", and US jobs data due on Friday.

This is because this may cause the Fed's "communicated and perceived narrative to drift away from dovish pivot expectations".

Ipek Ozkardeskaya added: "There is still hope that Fed President Jerome Powell talks about slower rate hikes at his speech this week, but again, his words shouldn't be heard halfway through. The Fed is willing to slow the pace of rate hikes to avoid going too far. But if they slow down, it's also because they want to go higher than 5%."

St Louis Federal Reserve President James Bullard affirmed on Monday that he believes the Federal Reserve will need to lift the federal funds rate to at least the bottom of a 5% to 7% range.

The benchmark rate is currently 3.75% to 4.00%.

Bullard's hawkishness was echoed by European Central Bank President Christine Lagarde who also signalled further interest rate hikes to come to come on Monday.

"I would like to see inflation having peaked in October but I'm afraid that I would not go as far as that," Lagarde told European lawmakers in Brussels.

Lagarde said the ECB has been hiking "at the fastest pace ever" and that more increases would be needed to bring inflation back down to the ECB's two-percent target.

"We still have a way to go and we're not done with inflation so, yes, we will continue to raise interest rates," Lagarde said.

Gold fetched USD1,752.70 an ounce, higher against USD1,743.16. Brent oil was quoted at USD85.35 a barrel early Tuesday, up from USD82.84 late Monday.

Still to come on Tuesday, there's a provisional CPI reading from Germany at 1300 GMT.

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.21% 10622 Delayed Quote.-5.31%
AUSTRALIAN DOLLAR / EURO (AUD/EUR) 0.00% 0.6535 Delayed Quote.2.57%
AUSTRALIAN DOLLAR / JAPANESE YEN (AUD/JPY) 0.00% 92.24 Delayed Quote.3.35%
AUSTRALIAN DOLLAR / US DOLLAR (AUD/USD) 0.00% 0.7103 Delayed Quote.4.40%
BRENT OIL -1.57% 86.05 Delayed Quote.1.71%
BRITISH POUND / EURO (GBP/EUR) 0.00% 1.1404 Delayed Quote.0.87%
BRITISH POUND / JAPANESE YEN (GBP/JPY) -0.02% 160.965 Delayed Quote.1.58%
BRITISH POUND / US DOLLAR (GBP/USD) 0.00% 1.2397 Delayed Quote.2.63%
CAC 40 0.02% 7097.21 Real-time Quote.9.63%
CANADIAN DOLLAR / EURO (CAD/EUR) -0.02% 0.691443 Delayed Quote.-0.04%
CANADIAN DOLLAR / JAPANESE YEN (CAD/JPY) -0.04% 97.496 Delayed Quote.0.75%
CANADIAN DOLLAR / US DOLLAR (CAD/USD) -0.01% 0.7507 Delayed Quote.1.73%
DAX 0.11% 15150.03 Delayed Quote.8.81%
EASYJET PLC -1.51% 507.2 Delayed Quote.56.25%
EURO / JAPANESE YEN (EUR/JPY) -0.02% 141.086 Delayed Quote.0.75%
EURO / US DOLLAR (EUR/USD) 0.01% 1.0866 Delayed Quote.1.78%
FTSE 100 0.05% 7765.15 Delayed Quote.4.21%
FTSE MID 250 INDEX 0.60% 20035.39 Delayed Quote.6.27%
HARGREAVES LANSDOWN PLC 1.20% 894.2 Delayed Quote.4.44%
INDIAN RUPEE / EURO (INR/EUR) 0.08% 0.011289 Delayed Quote.-0.13%
INDIAN RUPEE / JAPANESE YEN (INR/JPY) -0.38% 1.593625 Delayed Quote.0.87%
INDIAN RUPEE / US DOLLAR (INR/USD) -0.11% 0.012271 Delayed Quote.1.60%
JAPANESE YEN / SWISS FRANC (JPY/CHF) 0.07% 0.7091 Delayed Quote.0.60%
JOHN WOOD GROUP PLC 0.00% 144 Delayed Quote.6.55%
MSCI UNITED KINGDOM (STRD) 0.06% 1146.93 Real-time Quote.6.67%
NEW ZEALAND DOLLAR / JAPANESE YEN (NZD/JPY) 0.00% 84.32 Delayed Quote.1.15%
NEW ZEALAND DOLLAR / US DOLLAR (NZD/USD) 0.00% 0.6492 Delayed Quote.2.23%
NIKKEI 225 0.07% 27382.56 Real-time Quote.4.94%
S&P UNITED KINGDOM (PDS) 0.05% 1577.28 Real-time Quote.3.81%
S&P/ASX 200 0.34% 7493.8 Real-time Quote.6.47%
S&P/CITIC 300 INDEX 0.59% 3823.29 Real-time Quote.7.92%
S&P/CITIC 50 INDEX 0.44% 3716.67 Real-time Quote.7.89%
SYNCONA LIMITED 3.85% 178.2 Delayed Quote.-1.55%
TREATT PLC -0.32% 625 Delayed Quote.0.00%
US DOLLAR / EURO (USD/EUR) -0.01% 0.920302 Delayed Quote.-1.75%
US DOLLAR / JAPANESE YEN (USD/JPY) 0.00% 129.8 Delayed Quote.-0.99%
WTI -2.02% 79.45 Delayed Quote.0.75%
All news about ASTRAZENECA PLC
01/26US FDA Cancels Emergency Use Nod For AstraZeneca's COVID-19 Drug
01/26ADRs End Higher; AstraZeneca, Diageo Trade Actively
01/26AstraZeneca loses emergency use authorisation for Evusheld
01/26U.S. FDA pulls authorization for AstraZeneca's COVID-19 treatment Evusheld
01/26AstraZeneca's COVID-19 Therapy Evusheld Is No Longer Authorized for Emergency Use by US..
01/26FDA Halts Authorization of AstraZeneca's Evusheld for Prophylactic Use
01/26Astrazeneca plc Announces Update on US Food and Drug Administration Emergency Use Autho..
01/26Astrazeneca : Update on US Food and Drug Administration Emergency Use Authorisation of Evu..
01/26U.S. FDA withdraws authorization for AstraZeneca's Evusheld
01/26Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-lo..
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2022 44 454 M - -
Net income 2022 4 027 M - -
Net Debt 2022 24 214 M - -
P/E ratio 2022 51,0x
Yield 2022 2,24%
Capitalization 204 B 204 B -
EV / Sales 2022 5,13x
EV / Sales 2023 4,84x
Nbr of Employees 83 100
Free-Float 96,5%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 26
Last Close Price 131,52 $
Average target price 153,20 $
Spread / Average Target 16,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC-5.31%203 823
JOHNSON & JOHNSON-4.77%439 835
NOVO NORDISK A/S1.06%312 363
ROCHE HOLDING AG-0.40%277 685
MERCK & CO., INC.-5.02%267 180